S
SeaStar Medical Holding Corporation (ICU)
2.74
0.00 (0.00%)
Get all premium features to the best stock analysis tool
2.74
0.00 (0.00%)
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.66 | 6.05 | 10 | |
| Quick ratio | 3.64 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | 135K | 881K |
| Gross Profit | N/A | N/A | N/A | N/A | 480K |
| Operating Income | -4M | -9M | -14M | -18M | -14M |
| Net Income | -5M | -12M | -26M | -25M | -14M |
| EBITDA | -4M | -9M | -14M | -18M | -14M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 232.09 | 88 | 10 |
| Next quarter | 27.99 | 75 | 10 |
| Current year | 662.22 | 90.35 | 10 |
| Next year | 81.63 | 48.05 | 10 |
| Weighted average score | 10 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -45.85 | -73.42 | 27.78 | -27.83 | 3.3 |
| Y/Y | 169.12 | 22.47 | 88.18 | 23.15 | 10 |
| 3y average | 999 | -91.68 | 67.44 | -46.65 | 5.5 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 5.0 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Cash reserves $13.8M barely cover the upcoming debt maturities $0.0
Total current assets $14.9M exceed Total current liabilities $4.1M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$3.8M limits the company's ability to reinvest or pay down debt